1. Home
  2. SNV vs BIO Comparison

SNV vs BIO Comparison

Compare SNV & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNV
  • BIO
  • Stock Information
  • Founded
  • SNV 1888
  • BIO 1952
  • Country
  • SNV United States
  • BIO United States
  • Employees
  • SNV N/A
  • BIO N/A
  • Industry
  • SNV Major Banks
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • SNV Finance
  • BIO Industrials
  • Exchange
  • SNV Nasdaq
  • BIO Nasdaq
  • Market Cap
  • SNV 7.8B
  • BIO 9.1B
  • IPO Year
  • SNV N/A
  • BIO N/A
  • Fundamental
  • Price
  • SNV $53.58
  • BIO $336.21
  • Analyst Decision
  • SNV Buy
  • BIO Strong Buy
  • Analyst Count
  • SNV 19
  • BIO 4
  • Target Price
  • SNV $56.74
  • BIO $414.00
  • AVG Volume (30 Days)
  • SNV 1.2M
  • BIO 180.4K
  • Earning Date
  • SNV 01-15-2025
  • BIO 10-30-2024
  • Dividend Yield
  • SNV 2.87%
  • BIO N/A
  • EPS Growth
  • SNV N/A
  • BIO N/A
  • EPS
  • SNV 2.20
  • BIO N/A
  • Revenue
  • SNV $1,750,692,000.00
  • BIO $2,580,209,000.00
  • Revenue This Year
  • SNV N/A
  • BIO N/A
  • Revenue Next Year
  • SNV $11.27
  • BIO $3.61
  • P/E Ratio
  • SNV $24.09
  • BIO N/A
  • Revenue Growth
  • SNV N/A
  • BIO N/A
  • 52 Week Low
  • SNV $33.44
  • BIO $262.12
  • 52 Week High
  • SNV $59.92
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • SNV 44.78
  • BIO 49.20
  • Support Level
  • SNV $52.90
  • BIO $329.08
  • Resistance Level
  • SNV $57.12
  • BIO $351.08
  • Average True Range (ATR)
  • SNV 1.33
  • BIO 9.89
  • MACD
  • SNV -0.56
  • BIO 0.70
  • Stochastic Oscillator
  • SNV 13.65
  • BIO 55.68

About SNV Synovus Financial Corp.

Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: